Scientists who discovered migraine mechanism win £1.1m Brain prize

World’s largest neuroscience prize goes to researchers whose work has paved way for preventive treatments

Four scientists who discovered a key mechanism that causes migraines, paving the way for new preventive treatments, have won the largest prize for neuroscience in the world, sharing £1.1m.

The Lundbeck Foundation in Denmark announced on Thursday that the British researcher Peter Goadsby, Michael Moskowitz of the US, Lars Edvinsson of Sweden and Jes Olesen of Denmark had won the Brain prize.

Speaking at a press briefing ahead of the announcement, Goadsby, a professor of neurology at King’s College London, said: “I’m excited that migraine research is getting this award and that migraine – this disabling problem that is a brain disorder – is being recognised in an appropriate way.”

Formally known as the Grete Lundbeck European brain research prize, the annual award recognises highly original and influential advances in any area of brain research. The award ceremony will take place in Copenhagen on 25 October, where the prize will be presented by Crown Prince Frederik of Denmark.

The prize-winning research revolves around unpicking the neural basis of migraine, a crippling neurological condition characterised by episodes of throbbing head pain, as well as nausea, vomiting, dizziness, extreme sensitivity to sound, light, touch and smell. It affects about one in seven people globally and is about three times more common in women than men. In the UK, it is estimated that migraines result in the loss of 25m work or school days each year at an economic cost of £2.3bn.

For many years, migraine was thought to be a psychosomatic condition, resulting from people being unable to deal with stress. Although treatments were available, these only helped to relieve the symptoms, rather than addressing the root cause, which was unknown.

In 1979, Moskowitz, a professor of neurology at Harvard Medical School, proposed that migraines result from an interaction between the trigeminal nerve – involved in detecting sensations from the head and face – and the thin, pain-sensitive “meninges” membranes that surround the brain. He demonstrated that migraine attacks were triggered when trigeminal nerve fibres released chemicals called neuropeptides that caused the blood vessels of the meninges to dilate, resulting in inflammation and pain. He suggested that blocking the action of these neuropeptides could provide a new type of treatment.

Another breakthrough came when Goadsby, together with Edvinsson, a professor of internal medicine at Lund University in Sweden and the president of the International Headache Society, identified the key neuropeptide involved in triggering these attacks: calcitonin gene-related peptide (CGRP).

Further work by Olesen showed that when CGRP was given to migraine patients it could trigger an attack, and that drugs that blocked the neuropeptide could help treat migraine. In 2004, he and his team published the results of a large clinical trial suggesting that such “CGRP antagonist drugs” were effective in the acute treatment of migraine attacks.

This has led to the development of new treatments, including monoclonal antibody-based drugs such as erenumab, which is available in Europe and the US, and the small molecule drugs rimegepant and ubrogepant, which are as yet only available in the US. Although these drugs do not cure migraine, they markedly improve the quality of life of many patients, helping to both treat and prevent migraine attacks.

Goadsby said: “I think the important thing about this research is that it shows a neuroscience-based approach has value and that bench and bedside research married together has the ability to change clinical practice. I’m humbled by the emails that we get from patients whose lives have been changed by these medicines. We haven’t changed them all, we’ve only just started, but what this research shows is that migraine is a tractable problem.”

• This article was amended on 17 March 2021 to clarify that erenumab is not only available in the UK but in the rest of Europe and the US as well.


Linda Geddes

The GuardianTramp

Related Content

Article image
Scientists grow 'mini-brain on the move' that can contract muscle
Cambridge researchers grew ‘organoid’ that spontaneously connected to spinal cord

Hannah Devlin Science correspondent

18, Mar, 2019 @4:00 PM

Article image
Scientists develop AI that can turn brain activity into text
Researchers in US tracked the neural data from people while they were speaking

Nicola Davis

30, Mar, 2020 @3:00 PM

Article image
Human neurons transplanted into rats to help study brain disorders
Groundbreaking research could throw light on how cells from patients with neuropsychiatric disorders malfunction

Ian Sample Science editor

12, Oct, 2022 @3:07 PM

Article image
Alzheimer's link to herpes virus in brain, say scientists
Research reveals strains of virus more abundant in brains with early stage of disease, though uncertain whether virus is a trigger or a symptom

Hannah Devlin Science correspondent

21, Jun, 2018 @3:00 PM

Article image
Ultrasound trial offers hope for brain cancer patients
New technique temporarily allows drugs to cross blood brain barrier to treat tumours

Linda Geddes

13, Oct, 2021 @5:00 PM

Article image
Covid can shrink brain and damage its tissue, finds research
Worst effect on region linked to smell, while infected people typically scored lower on mental skills test

Linda Geddes and Ian Sample

07, Mar, 2022 @4:05 PM

Article image
Covid-19 may cause brain complications in some, say doctors
Stroke and psychosis found in small study of patients highlight need for research

Hannah Devlin Science correspondent

26, Jun, 2020 @7:26 AM

Article image
Brain scans can spot criminals, scientists say
Experiments prove judicial distinction between criminal intent and reckless behaviour has scientific merit too

Ian Sample Science editor

13, Mar, 2017 @7:00 PM

Article image
Scientists discover brain signals for chronic pain
Discovery of ‘objective biomarker’ raises hopes for new treatments for people living with intractable pain

Ian Sample Science editor

22, May, 2023 @3:00 PM

Article image
Scientists identify parts of brain involved in dreaming
Experts say findings are ‘astounding’ and could help understand the purpose of dreams and predict whether people are dreaming

Nicola Davis

10, Apr, 2017 @3:00 PM